Dergiler / Turkish Journal of Gastroenterology / 2019 / Cilt: 30 - Sayı: 8

Bacterial infections in cirrhotic patients

Sayfa
767–768
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

BAŞ, B. Ö., ÇEKİN, A. H. (2019). Bacterial infections in cirrhotic patients. Turkish Journal of Gastroenterology, Cilt: 30 - Sayı: 8, 767–768. https://ajindex.com/articles/409883

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Jalan R, Fernandez J, Wiest R, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. J Hepatol 2014; 60: 1310-24. [CrossRef] 2. Bajaj JS, O’Leary JG, Reddy KR, et al. Survival in infectionrelated acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology 2014; 60: 250-6. [CrossRef] 3. Schmidt ML, Barritt AS, Orman ES, et al. Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010. Gastroenterology 2015; 148: 967-77.e2. [CrossRef] 4. Fernández J, Acevedo J, Castro M, et al. Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 2012; 55: 1551-61. [CrossRef] 5. Bajaj JS, O’Leary JG, Reddy KR, et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: The North American Consortium for the Study of End-Stage Liver Disease (NACSELD) experience. Hepatology 2012; 56: 2328-35. [CrossRef] 6. Merli M, Lucidi C, Gregorio V Di, et al. The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey. PLoS One 2015; 10: e0127448. [CrossRef] 7. Tandon P, DeLisle A, Topal JE, et al. High prevalence of antibiotic-resistant bacterial infections among patients with cirrhosis at a US liver center. Clin Gastroenterol Hepatol 2012; 10: 1291-8. [CrossRef] 8. Cheong HS, Kang C, Lee JA, et al. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis. Clin Infect Dis 2009; 48: 1230-6. [CrossRef] 9. Moreau R, Elkrief L, Bureau C, et al. Effects of long-term norfloxacin therapy in patients with advanced cirrhosis. Gastroenterology 2018; 155: 1816-27.e9. [CrossRef] 10. Piano S, Bartoletti M, Tonon M, et al. Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections. Gut 2018; 67: 1892-9. [CrossRef] 11. Çelik G, Köksal R, Bedir F, et al. Infections with resistant bacteria in hospitalized cirrhotic patients cause longer hospital stay and frequent icu transfer. J Hepatol 2014; 60: 215-359. [CrossRef]